Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar Combined With TP Regimen for Chemoradiotherapy in Esophageal Cancer
NCT04164797Phase 4Unknown
- Sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Nov 2019
- Primary completion
- Jul 2021
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of endostar in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Second Affiliated Hospital of Xi'an Jiaotong University. Status: unknown.
02
Drugs
endostar
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT04164797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04164797.